APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination
- PMID: 31448897
- PMCID: PMC7211764
- DOI: 10.1021/acs.biochem.9b00394
APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination
Abstract
The apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3 or A3) family of proteins functions in the innate immune system. The A3 proteins are interferon inducible and hypermutate deoxycytidine to deoxyuridine in foreign single-stranded DNA (ssDNA). However, this deaminase activity cannot discriminate between foreign and host ssDNA at the biochemical level, which presents a significant danger when A3 proteins gain access to the nucleus. Interestingly, this A3 capability can be harnessed when coupled with novel CRISPR-Cas9 proteins to create a targeted base editor. Specifically, A3A has been used in vitro to revert mutations associated with disease states. Recent structural studies have shown the importance of loop regions of A3A and A3G in ssDNA recognition and positioning for deamination. In this work, we further examined loop 1 of A3A to determine how it affects substrate selection, as well as the efficiency of deamination, in the hopes of advancing the potential of A3A in base editing technology. We found that mutating residue H29 enhanced deamination activity without changing substrate specificity. Also interestingly, we found that increasing the length of loop 1 decreases substrate specificity. Overall, these results lead to a better understanding of substrate recognition and deamination by A3A and the A3 family of proteins.
Figures






Similar articles
-
Creating RNA Specific C-to-U Editase from APOBEC3A by Separation of Its Activities on DNA and RNA Substrates.ACS Synth Biol. 2021 May 21;10(5):1106-1115. doi: 10.1021/acssynbio.0c00627. Epub 2021 May 2. ACS Synth Biol. 2021. PMID: 33938211
-
Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.Nucleic Acids Res. 2014 Jan;42(2):1095-110. doi: 10.1093/nar/gkt945. Epub 2013 Oct 24. Nucleic Acids Res. 2014. PMID: 24163103 Free PMC article.
-
Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.Sci Rep. 2018 May 14;8(1):7511. doi: 10.1038/s41598-018-25881-z. Sci Rep. 2018. PMID: 29760455 Free PMC article.
-
Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.J Gen Virol. 2016 Jan;97(1):1-17. doi: 10.1099/jgv.0.000320. Epub 2015 Oct 20. J Gen Virol. 2016. PMID: 26489798 Free PMC article. Review.
-
APOBEC: From mutator to editor.J Genet Genomics. 2017 Sep 20;44(9):423-437. doi: 10.1016/j.jgg.2017.04.009. Epub 2017 Aug 7. J Genet Genomics. 2017. PMID: 28964683 Review.
Cited by
-
Structure-Guided Design of a Potent and Specific Inhibitor against the Genomic Mutator APOBEC3A.ACS Chem Biol. 2022 Dec 16;17(12):3379-3388. doi: 10.1021/acschembio.2c00796. Epub 2022 Dec 8. ACS Chem Biol. 2022. PMID: 36475588 Free PMC article.
-
Design and Engineering of Light-Induced Base Editors Facilitating Genome Editing with Enhanced Fidelity.Adv Sci (Weinh). 2024 Feb;11(5):e2305311. doi: 10.1002/advs.202305311. Epub 2023 Dec 1. Adv Sci (Weinh). 2024. PMID: 38039441 Free PMC article.
-
Simultaneous detection of 5-methylcytosine and 5-hydroxymethylcytosine at specific genomic loci by engineered deaminase-assisted sequencing.Chem Sci. 2024 May 20;15(26):10073-10083. doi: 10.1039/d4sc00930d. eCollection 2024 Jul 3. Chem Sci. 2024. PMID: 38966352 Free PMC article.
-
Human activation-induced deaminase lacks strong replicative strand bias or preference for cytosines in hairpin loops.Nucleic Acids Res. 2022 May 20;50(9):5145-5157. doi: 10.1093/nar/gkac296. Nucleic Acids Res. 2022. PMID: 35524550 Free PMC article.
-
Engineering of Peptide-Inserted Base Editors with Enhanced Accuracy and Security.Small. 2025 Apr;21(14):e2411583. doi: 10.1002/smll.202411583. Epub 2025 Feb 25. Small. 2025. PMID: 39995348 Free PMC article.
References
-
- Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinski M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, Totoki Y, Tutt AN, Valdes-Mas R, van Buuren MM, van ‘t Veer L, Vincent-Salomon A, Waddell N, Yates LR, Australian Pancreatic Cancer Genome, I., Consortium, I. B. C., Consortium, I. M.-S., PedBrain I, Zucman-Rossi J, Futreal PA, McDermott U, Lichter P., Meyerson M., Grimmond SM, Siebert R, Campo E, Shibata T, Pfister SM, Campbell PJ, and Stratton MR (2013) Signatures of mutational processes in human cancer, Nature 500, 415–421. - PMC - PubMed
-
- Harris RS, Petersen-Mahrt SK, and Neuberger MS (2002) RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators, Mol Cell 10, 1247–1253. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources